Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
We review the 2024 average FICO score, what it implies for loan pricing, and practical steps to improve beyond the average.
8,862 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A Nvidia-backed AI infrastructure player is quietly reshaping how enterprises train and run AI. This piece breaks dow...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
A fresh retirement rule laid out on a March 2026 podcast reframes how affluent savers think about income in retiremen...
Market pullbacks can feel daunting, but they’re prime opportunities for long-term gains. This guide reveals how to id...
When a stock climbs 15% after a fund trims its position, investors should look beyond the headline. This article brea...
Curious about a strategy that blends stock ownership with option income? This deep-dive on the JPMorgan Equity Premiu...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Mortgage lenders are shifting from deal-by-deal momentum to long-term advisory relationships, redefining growth in a ...
IBM is capturing attention this week with a blend of quantum computing momentum and AI-powered cybersecurity initiati...
Oil climbs above $100 per barrel as tensions surface around Iran. Gas prices push near $4.60 a gallon ahead of Memori...